Company Profile

EXOSYSTEMS Inc. was established as a spin-off company of ETRI(Electronics and Telecommunications Research Institute) in 2017 and the goal is to commercialize the A.I.-powered healthcare with our technology.

Our main focus fields are digital medical devices and digital therapeutics.
The digital medical device focus on saving time and money for those in need of post-neurotic surgery rehabilitation. Also, we focus our capabilities on developing technology and products that can be used comfortably and consistently for rehabilitation at home and can improve the health status of the elderly, whose physical functions naturally weaken due to aging.

Based on our own robotics and ICT technology capabilities, we are developing musculoskeletal healthcare products that can be used in daily life, which has led to the development of musculoskeletal healthcare solutions and services in line with the rehabilitation of brain disease patients and the approaching aging society, and has now been commercialized under the name of 'exoRehab'.

Company History

January, 2022 Series-A funding of 4.5 billion attracted
March, 2021 Selected in Korea Nano-Integrated Innovative Product & Tech Development Project(2.6 billion won)
February, 2021 'exoRehab' Registered as innovative product in Public Procurement Service
January, 2020 CES Innovation Award Honoree in 'Health & Wellness' and 'Tech for Better World' fields
January, 2019 Award by Minister of Science and ICT, Korea Invention Patent Exhibition
February, 2017 60 million seed Investment from Kakao Ventures, SparkLabs
January, 2017 Incorporated

Factory / Branch Office

  • at
  • at
  • at
  • at
  • at

EXOSYSTEMS Inc. (https://ko.exosystems.io/)

  • The person in charge

    Hooman Lee
  • Telephone

  • Fax

  • Address

    815 Daewangpangyo-ro Sujeong-gu, Seongnam-si, Gyeonggi-do (13449)
Business Type Manufacturer
Main Product exoRehab, exoPill
Established 2017-01-04
Total Annual Revenue 3~5 million (KRW)
Total Employees 11~50 people